Yonghua Capital
VC Fund
Shanghai, China
Yonghua Capital is a VC fund in Shanghai focused on Manufacturing and Health Care. Shanghai Chung Hua Investment Management Co., Ltd. is specialized in Yongjin Group's equity investment management platform. Total investment scale Chung Hua invest over 6 billion yuan, it has invested in more than 80 outstanding enterprises, of which more than 40 enterprises have been successfully listed. Currently Chung Hua investment team covering the major cities Beijing, Shanghai, Shenzhen, Xiamen, Hangzhou, Changsha, Chengdu, etc., and in many industries new energy, environmental protection, consumer goods, TMT, agriculture and other in-depth research team.
- Total investments:
- 175
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Yonghua Capital invests in
Stages Yonghua Capital invests in
Countries Yonghua Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $158k–$15M
- Series A
- $1.5M–$48M
- Series B
- $3M–$72M
Investment Focus
Industry
- Manufacturing 26 (15%)
- Health Care 19 (11%)
- Education 17 (10%)
- Artificial Intelligence 17 (10%)
- Software 15 (9%)
Stage
- Series A 61 (35%)
- Series B 34 (19%)
- Seed 21 (12%)
- Angel 16 (9%)
- Series C 10 (6%)
Country
- China 119 (68%)
- United States 9 (5%)
- Canada 2 (1%)
- Japan 1 (1%)
- Belgium 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Li Yang
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
|
Moses Zhao
Co-Founder & Managing Director
|
Co-Founder & Managing Director | Total investments: 1 | Find email | |
|
Zhang Chen
Deputy Director
|
Deputy Director | Total investments: 1 | Find email | |
|
Zhang Shuai
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sequence Technology
|
Sequence Technology emphasizes in the production of polymer materials used in the semiconductor manufacturing process. | $14.9M / Series B / Sep 17, 2026 | |
| Biyi Laser refers to a technology that uses laser beams as information carriers to directly transmit voice, data, and images at high speed and in a bidirectional manner, offering advantages such as high bandwidth, strong anti-interference capability, enhanced security, and flexible deployment for applications in communications, data transmission,and advanced information systems. | Series B / Jul 29, 2026 | ||
| Established in 2020, Shanghai Shexu Technology Co., Ltd. is an AI-driven industrial design software R&D technology enterprise and design service provider. The company has a professional scientific research and technical team, and has independently developed automatic industrial design software based on AI computing engine. The design softwarehas been widely used in the field of automotive industry equipment, significantly improving the design efficiency of industrial machinery designers. | $14.8M / Series B / Jul 23, 2026 | ||
Tianhu Technology
|
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider. | Series A / Jul 13, 2026 | |
| Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles. | $14.7M / Series A / May 06, 2026 | ||
| Minyue provides intelligent welding solutions that include a laser vision seam tracking system, a light vision sensor, and off-line programming software for industrial robots. They solve the programming problems of industrial robots in various complex applications, and the company has developed offline programming software for industrial robots. | Series B / Apr 16, 2026 | ||
|
Tianhu Technology
|
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider. | $29M / Series A / Mar 16, 2026 | |
| C12.ai is an artificial intelligence company that develops AI-powered drug discovery and laboratory automation platforms for the biotechnology and life sciences sectors. Its solutions combine machine learning, data science, and automated experimentation to support research, molecular discovery, and scientific decision-making across pharmaceuticaland biotech applications. | $7.3M / Seed / Mar 12, 2026 | ||
| UniX AI possesses advanced research and development capabilities in the domain of embodied intelligent robotics. The team comprises specialists from various disciplines, including structural engineering, electronics, algorithms, and deep learning. This technology company focuses on enhancing the robot's ability to generalize in intricatescenarios. | $43.7M / Venture - Series Unknown / Mar 02, 2026 | ||
| Myactuator is an intelligent technology company that specializes in the design, simulation, and development of robot actuators and control systems. | Series A / Mar 02, 2026 | ||
| See all 175 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Yonghua Capital invest in?
Yonghua Capital invests primarily in Manufacturing, Health Care and Education startups, most often at Series A and Series B stage. Most of the 175 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Yonghua Capital invest in?
Yonghua Capital typically joins rounds of $158k–$15M at Seed, $1.5M–$48M at Series A and $3M–$72M at Series B. These are whole funding-round sizes, not Yonghua Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yonghua Capital took part in.
How do I contact Yonghua Capital?
Public channels for Yonghua Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Yonghua Capital?
The team at Yonghua Capital includes Li Yang (Executive Director), Moses Zhao (Co-Founder & Managing Director) and Zhang Chen (Deputy Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
